Adnexus clinical trials
Acquired by Bristol-Myers Squibb, Oct 19, 2007 · source ↗
The registry lists 3 studies whose lead sponsor is Adnexus. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 27, 2010.
Before and after it joined Bristol-Myers Squibb
- First submitted before Adnexus became part of Bristol-Myers Squibb
- 1
- First submitted after Adnexus became part of Bristol-Myers Squibb
- 2
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Adnexus, A Bristol-Myers Squibb R&D Company3 studies
Something wrong with this grouping? Tell us on the Bristol-Myers Squibb page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Bristol-Myers Squibb studies →
- CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With IrinotecanStatus unknownNCT00562419Phase 2
Sponsor listed in the registry: Adnexus, A Bristol-Myers Squibb R&D Company · First submitted after Adnexus became part of Bristol-Myers Squibb
- CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma MultiformeStatus unknownNCT00768911Phase 1
Sponsor listed in the registry: Adnexus, A Bristol-Myers Squibb R&D Company · First submitted after Adnexus became part of Bristol-Myers Squibb
- CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's LymphomaCompletedNCT00374179Phase 1
Sponsor listed in the registry: Adnexus, A Bristol-Myers Squibb R&D Company · First submitted before Adnexus became part of Bristol-Myers Squibb